News for DARA Biosciences Inc - Google Finance

DARA BIOSCIENCES INC : DARA Reports First Quarter 2013 Financial Results ...

Wed, 15 May 2013 22:03:11 GMT

DARA BIOSCIENCES INC : DARA Reports First Quarter 2013 Financial Results ...
4-traders (press release) - May 15, 2013

RALEIGH, NC -- (Marketwired) -- 05/15/13 -- DARA BioSciences, Inc.(NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today its financial results for the first quarter ended March ...

Stocks Closing In The Green: DARA Biosciences Inc (NASDAQ:DARA), Entropic ...

Mon, 29 Apr 2013 01:42:12 GMT

Stocks Closing In The Green: DARA Biosciences Inc (NASDAQ:DARA), Entropic ...
NIS - Apr 29, 2013

New York, NY - (NISMAGAZINE) - 4/28/2013- DARA Biosciences Inc (NASDAQ:DARA) gained 1.84% at $0.780 after trading 304,741 shares.

Noranda Aluminum Holding Corporation (NYSE:NOR) down by 6.99%, DARA ...

Thu, 25 Apr 2013 17:33:42 GMT

Noranda Aluminum Holding Corporation (NYSE:NOR) down by 6.99%, DARA ...
NIS - Apr 25, 2013

New York, NY - (NISMAGAZINE) - 04/25/2013- Noranda Aluminum Holding Corporation (NYSE:NOR) moved 6.99% lower, at $4.14, was amongst the day losers, after opening at $4.22.

Noranda Aluminum Holding Corporation (NYSE:NOR) up by 28.18%, DARA ...

Wed, 24 Apr 2013 17:07:13 GMT

Noranda Aluminum Holding Corporation (NYSE:NOR) up by 28.18%, DARA ...
NIS - Apr 24, 2013

New York, NY - (NISMAGAZINE) - 04/24/2013- Noranda Aluminum Holding Corporation (NYSE:NOR) moved 28.18% higher, at $4.23, was among the day gainers, after opening at $3.32.

BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors

Mon, 29 Apr 2013 11:02:16 GMT

BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
MarketWatch (press release) - Apr 29, 2013

Mr. D'Alonzo's extensive pharmaceutical industry background also includes a number of executive positions, including Chief Executive Officer at biotechnology companies DARA BioSciences, Inc. and GenVec, Inc. and President and Chief Operating Officer at ...

DARA Biosciences Inc Announces Submission Of Krn5500 To FDA For Orphan Designation

Thu, 29 Nov 2012 13:00:00 GMT

DARA Biosciences Inc Announces Submission Of Krn5500 To FDA For Orphan Designation
Reuters Key Development - Nov 29, 2012

Helsinn Group Grants To DARA Biosciences Inc Exclusive U.S. Commercial Rights To Gelclair

Thu, 13 Sep 2012 12:30:00 GMT

Helsinn Group Grants To DARA Biosciences Inc Exclusive U.S. Commercial Rights To Gelclair
Reuters Key Development - Sep 13, 2012

DARA Biosciences Inc Announces Launch Of Bionect For Treatment Of Skin Irritation And Burns Associated With Radiation Therapy For Cancer

Wed, 06 Jun 2012 12:45:00 GMT

DARA Biosciences Inc Announces Launch Of Bionect For Treatment Of Skin Irritation And Burns Associated With Radiation Therapy For Cancer
Reuters Key Development - Jun 6, 2012

DARA Biosciences Inc Announces Appointment Of President

Tue, 29 May 2012 12:45:00 GMT

DARA Biosciences Inc Announces Appointment Of President
Reuters Key Development - May 29, 2012

DARA Biosciences Inc Announces New Analysis of Patient Self-Reported Diary Results In A Phase 2a Clinical Trial Of KRN5500 In Patients With Cancer And Neuropathic Pain

Wed, 09 May 2012 12:45:00 GMT

DARA Biosciences Inc Announces New Analysis of Patient Self-Reported Diary Results In A Phase 2a Clinical Trial Of KRN5500 In Patients With Cancer And Neuropathic Pain
Reuters Key Development - May 9, 2012